Human iPS Cells: Science and Ethics

Crook, Jeremy Micah
January 2010
Open Stem Cell Journal;2010 Special Issue, p1
Academic Journal
An introduction to the journal is presented in which the editor discusses articles on the science and ethic of human induced pluripotent stem (iPS) cells, the human somatic cell reprogramming, and the biological equivalent of the iPS and embryonic stem (ES) cells.


Related Articles

  • Yamanaka factors critically regulate the developmental signaling network in mouse embryonic stem cells. Liu, Xiaosong; Huang, Jinyan; Chen, Taotao; Wang, Ying; Xin, Shunmei; Li, Jian; Pei, Gang; Kang, Jiuhong // Cell Research;Dec2008, Vol. 18 Issue 12, p1177 

    Yamanaka factors (Oct3/4, Sox2, Klf4, c-Myc) are highly expressed in embryonic stem (ES) cells, and their over-expression can induce pluripotency in both mouse and human somatic cells, indicating that these factors regulate the developmental signaling network necessary for ES cell pluripotency....

  • Stem Cells: Panacea or Pandora's Box? McCaffrey, Ryan M. // Harvard Salient;4/24/2008, p8 

    The article discusses the dispute over the issue of using human embryonic stem (ES) in research. The benefit of ES research is said to be infinite for the improvement of clinical treatments of various medical conditions. Critics of ES cell research argue that it is a degradation of human life...

  • Engineered embryonic stem cells for regnerative nedicine. Hescheler, J. // Cell Research;Aug2008 Supplement, Vol. 18, pS111 

    Due to their ability to reproduce the embryological differentiation of nearly all different cellular phenotypes, embryonic stem (ES) cells represent an ideal tool to study processes of embryogenesis under in vitro conditions, in particular the signalling cascades and genes involved in the...

  • In Brief.  // Nature Reviews Molecular Cell Biology;Jun2009, Vol. 10 Issue 6, p369 

    The article presents news briefs of research in molecular cell biology. Protein phosphatase 1 (PP1) dephosphorylates mitotic phosphoproteins and its method of inhibition is described. Special AT-rich sequence-binding protein 1 (SATB1) is only expressed in embryonic stem (ES) cells. S5a...

  • Balancing open source stem cell science with commercialization. Courtney, Aidan; De Sousa, Paul; George, Carol; Laurie, Graeme; Tait, Joyce // Nature Biotechnology;Feb2011, Vol. 29 Issue 2, p115 

    A letter exploring the issues surrounding open source stem cell science and research in Great Britain is presented. It reflects on how British regulations on stem cell science favor basic research but restrict commercial investment. It provides an overview of the British governance system for...

  • Embryonic stem cells: the moral dilemma of patentability and funding. San Martín, Beatriz // Pharmaceutical Technology Europe;Sep2009, Vol. 21 Issue 9, p50 

    The article discusses the increasing moral debate concerning the patentability and finance of human embryonic stem cells (hES) development in Europe. The author asserts that hES cell research has gained wide interest from scientist because it contains since it allows them to gain better...

  • California Leads, but a Pack Follows. Chu, Jeff; Ferkenhoff, Eric; Kauffman, Elisabeth; McCarthy, Terry // Time International (South Pacific Edition);5/23/2005, Issue 20, p20 

    The article presents information on the initiative of several states in human embryonic-stem-cell research in the U.S. Human embryonic-stem-cell research remains technically legal in almost every state. Seven states restrict research, including Michigan, which prohibits it on live embryos,...

  • Chapter 5: STEM-CELL RESEARCH.  // When Religion & Politics Mix: How Matters of Faith Influence Pol;2005, p70 

    This article describes the role played by religion in the current debates over stem-cell research in the U.S. A brief discussion of stem-cell research is offered. The attitudes of U.S. citizens toward stem-cell research are examined. The stance of the Catholic Church as well as other religious...

  • Embryonic Stem Cell Research Advances, But Obstacles Remain. Morrison, Trista // BioWorld Today;9/26/2007, Vol. 18 Issue 187, p1 

    The article reports on the development of embryonic stem cell research despite limits on government support and intellectual property disputes, according to a panel stem cell experts. Elizabeth Donley of Stemina Biomarket Discovery Inc. said her company uses stem cells as bioreactors. According...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics